Teva Pharma (TEVA) Cut to Junk by S&P; to BB/Stable from BBB-/Watch
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $36.36 -0.71%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -5.4%
Join SI Premium – FREE
Teva Pharma (NYSE: TEVA) Cut to Junk at S&P; to BB/Stable from BBB-/Watch
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Teva Pharma (TEVA) PT Raised to $48 at UBS
- Alpha Compute reports $1.57M monthly cash flow and $1.5B pipeline
- Seagate board member Arumugavelu to step down at annual meeting
Create E-mail Alert Related Categories
Corporate News, Credit RatingsRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
